Found: 119
Select item for more details and to access through your institution.
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 10, p. 2554, doi. 10.1002/eji.201343324
- By:
- Publication type:
- Article
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 11, p. 3114, doi. 10.1002/eji.201141836
- By:
- Publication type:
- Article
Influenza matrix 1-specific human CD4.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 11, p. 3064, doi. 10.1002/eji.200940177
- By:
- Publication type:
- Article
Human Papillary and Reticular Fibroblasts Show Distinct Functions on Tumor Behavior in 3D-Organotypic Cultures Mimicking Melanoma and HNSCC.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11651, doi. 10.3390/ijms231911651
- By:
- Publication type:
- Article
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8707, doi. 10.3390/ijms23158707
- By:
- Publication type:
- Article
Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1989, doi. 10.3390/jcm8111989
- By:
- Publication type:
- Article
Characterization of the early cellular immune response induced by HPV vaccines.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.863164
- By:
- Publication type:
- Article
Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.924099
- By:
- Publication type:
- Article
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.
- Published in:
- International Journal of Cancer, 1997, v. 73, n. 1, p. 125, doi. 10.1002/(SICI)1097-0215(19970926)73:1<125::AID-IJC19>3.0.CO;2-F
- By:
- Publication type:
- Article
Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitope.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 6, p. 1122, doi. 10.1002/(SICI)1097-0215(19970917)72:6<1122::AID-IJC30>3.0.CO;2-3
- By:
- Publication type:
- Article
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope.
- Published in:
- International Journal of Cancer, 1997, v. 70, n. 3, p. 302, doi. 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO;2-H
- By:
- Publication type:
- Article
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 1, p. 81, doi. 10.1038/nm.3773
- By:
- Publication type:
- Article
Interferon‐γ and IL‐5 associated cell‐mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosa.
- Published in:
- Clinical & Experimental Dental Research, 2021, v. 7, n. 5, p. 903, doi. 10.1002/cre2.396
- By:
- Publication type:
- Article
Features of effective T Cell-inducing vaccines against Chronic viral infections.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00276
- By:
- Publication type:
- Article
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1<sup>b</sup> with TAP-Independent Peptides Are Semi-Invariant Lymphocytes.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00060
- By:
- Publication type:
- Article
SPONTANEOUSLY INDUCED CELLULAR IMMUNITY TO HPV-16/18 AND THE THERAPEUTIC VACCINATION OF PATIENTS WITH HPV-16/18 (PRE-)MALIGNANT LESIONS.
- Published in:
- Central European Journal of Public Health, 2008, v. 16, p. S16
- By:
- Publication type:
- Article
Perspectives from the leadership of Journal for ImmunoTherapy of Cancer.
- Published in:
- Journal of International Society of Preventive & Community Dentistry, 2024, v. 14, n. 3, p. 1, doi. 10.1136/jitc-2024-009661
- By:
- Publication type:
- Article
Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104230
- By:
- Publication type:
- Article
Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017848
- By:
- Publication type:
- Article
Evaluation of Immunological Cross-Reactivity between Clade A9 High-Risk Human Papillomavirus Types on the Basis of E6-Specific CD4+ Memory T Cell Responses.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 8, p. 1200, doi. 10.1086/656367
- By:
- Publication type:
- Article
p53: A Potential Target Antigen for Immunotherapy of Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 910, n. 1, p. 223, doi. 10.1111/j.1749-6632.2000.tb06711.x
- By:
- Publication type:
- Article
Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03755-w
- By:
- Publication type:
- Article
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1553, doi. 10.1007/s00262-022-03350-x
- By:
- Publication type:
- Article
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 289, doi. 10.1007/s00262-021-02984-7
- By:
- Publication type:
- Article
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 771, doi. 10.1007/s00262-020-02506-x
- By:
- Publication type:
- Article
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 9, p. 1163, doi. 10.1007/s00262-017-2006-y
- By:
- Publication type:
- Article
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 7, p. 903, doi. 10.1007/s00262-017-1991-1
- By:
- Publication type:
- Article
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 7, p. 913, doi. 10.1007/s00262-017-1995-x
- By:
- Publication type:
- Article
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1451, doi. 10.1007/s00262-016-1892-8
- By:
- Publication type:
- Article
A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17 cell frequency.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 4, p. 393, doi. 10.1007/s00262-016-1805-x
- By:
- Publication type:
- Article
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 161, doi. 10.1007/s00262-015-1782-5
- By:
- Publication type:
- Article
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 10, p. 1271, doi. 10.1007/s00262-015-1729-x
- By:
- Publication type:
- Article
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 9, p. 1109, doi. 10.1007/s00262-015-1716-2
- By:
- Publication type:
- Article
Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 585, doi. 10.1007/s00262-014-1649-1
- By:
- Publication type:
- Article
Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8 T cells with detection by ELISPOT and HLA-multimer staining.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 11, p. 1199, doi. 10.1007/s00262-014-1593-0
- By:
- Publication type:
- Article
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 147, doi. 10.1007/s00262-013-1499-2
- By:
- Publication type:
- Article
Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1161, doi. 10.1007/s00262-013-1411-0
- By:
- Publication type:
- Article
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 615, doi. 10.1007/s00262-012-1359-5
- By:
- Publication type:
- Article
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 489, doi. 10.1007/s00262-012-1351-0
- By:
- Publication type:
- Article
The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 11, p. 1953, doi. 10.1007/s00262-012-1251-3
- By:
- Publication type:
- Article
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 9, p. 1485, doi. 10.1007/s00262-012-1292-7
- By:
- Publication type:
- Article
Harmonization of the intracellular cytokine staining assay.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 7, p. 967, doi. 10.1007/s00262-012-1282-9
- By:
- Publication type:
- Article
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 953, doi. 10.1007/s00262-011-1004-8
- By:
- Publication type:
- Article
Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1390, doi. 10.3390/cancers14061390
- By:
- Publication type:
- Article
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6366, doi. 10.3390/cancers13246366
- By:
- Publication type:
- Article
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5179, doi. 10.3390/cancers13205179
- By:
- Publication type:
- Article
Future Challenges in Cancer Resistance to Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 935, doi. 10.3390/cancers12040935
- By:
- Publication type:
- Article
Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1102, doi. 10.3390/cancers11081102
- By:
- Publication type:
- Article
Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 845, doi. 10.3390/cancers11060845
- By:
- Publication type:
- Article
Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells.
- Published in:
- Cytometry. Part A, 2015, v. 87, n. 1, p. 37, doi. 10.1002/cyto.a.22575
- By:
- Publication type:
- Article